Eaton Vance Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$393K Sell
15,641
-8
-0.1% -$222 ﹤0.01% 1382
2022
Q2
$476K Sell
15,649
-12,152
-44% -$363K ﹤0.01% 1380
2022
Q1
$911K Buy
27,801
+12,152
+78% +$361K ﹤0.01% 1388
2021
Q4
$413K Hold
15,649
﹤0.01% 1368
2021
Q3
$1.57M Hold
15,649
﹤0.01% 986
2021
Q2
$2.21M Sell
15,649
-277
-2% -$31.3K ﹤0.01% 988
2021
Q1
$1.59M Buy
15,926
+285
+2% +$33.2K ﹤0.01% 1025
2020
Q4
$1.93M Sell
15,641
-18
-0.1% -$2.37K ﹤0.01% 937
2020
Q3
$1.53M Hold
15,659
﹤0.01% 903
2020
Q2
$2.44M Buy
15,659
+18
+0.1% +$2.74K 0.01% 765
2020
Q1
$2.26M Hold
15,641
0.01% 735
2019
Q4
$3.2M Buy
15,641
+4,694
+43% +$856K 0.01% 731
2019
Q3
$879K Hold
10,947
﹤0.01% 1001
2019
Q2
$1.03M Buy
+10,947
New +$945K ﹤0.01% 950

Other funds holding RETA